SCHEMBL7053900

SCHEMBL7053900

CNCCC(Oc1cccc(OC)c1)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 15/20 0.75
SLC6A2 P23975 6/20 0.64
CYP2D6 P10635 5/20 0.63
CYP2C19 P33261 3/20 0.63
MEN1 O00255 2/20 0.63
CYP1A2 P05177 2/20 0.63
CYP3A4 P08684 2/20 0.63
TSHR P16473 2/20 0.63
KMT2A Q03164 2/20 0.63
SLC6A3 Q01959 2/20 0.63
NOS2 P35228 2/20 0.62
PMP22 Q01453 1/20 0.62
NPC1 O15118 2/20 0.58
MTOR P42345 2/20 0.58
RAB9A P51151 2/20 0.58
KDM4E B2RXH2 1/20 0.58
TP53 P04637 1/20 0.58
CYP2C9 P11712 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5268848 0.87 SLC6A4 (0.82) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL5011928 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL8197696 0.86 SLC6A4 (1.00) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL5014117 0.86 SLC6A4 (0.75) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL30163449 0.86 SLC6A4 (0.75) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL1200912 0.86 SLC6A4 (0.75) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL1200769 0.86 SLC6A4 (0.75) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL31733949 0.86 SLC6A4 (0.75) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
Hydrochloric Acid SCHEMBL4941345 0.85 SLC6A4 (0.97) SLC6A4SLC6A2CYP2D6CYP2C19MEN1
SCHEMBL14607953 0.84 SLC6A4 (1.00) SLC6A4SLC6A2CYP2D6CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed